Staff Profile

I am a PI in the Translational and Clinical Research Institute and a Professor Emeritus of Thoracic Medicine in the faculty of Medical Sciences

I am a a distinguished Clinician Scientist  and have been recognised by election to Presidencies of the International Society for Heart and Lung Transplantation and British Thoracic Societies. I am President Elect of the international Pulmonary Vascular Research Institute

CURRENT APPOINTMENTS

Professor of Thoracic Medicine Translational and Clinical Research Institute Newcastle University

Hon Consultant Physician, Regional Cardiothoracic Centre, Freeman Hospital Newcastle

Chief Medical Scientific Officer PVRI

Chairman Board PVRI

ESTEEM INDICATORS

1979 Class prize in Surgery (Proxime Accessit)

1984 Medical Research Society Eli-Lily Prize

1986 British Thoracic Society/Fisons Travelling Fellowship

1999 Bradshaw Lecture, Royal College of Physicians London

2000 Visiting Professor University of Western Australia

2004 Supervisor British Thoracic Society/British Lung Foundation Young scientist of the year

2008 Supervisor European Respiratory Society Best young scientist prize

2006-2008 President European Society for Heart and Lung Transplantation

2007-2008 President International Society for Heart and Lung Transplantation

2009-2010 President British Thoracic Society

2007 Key Science Lecture Medical Research Institute University of Barcelona

2008 Honeyman Gillespie Lecture Edinburgh University

2009 Appointed member Faculty of 1000

2010 Senior Fellow Spanish Transplantation Society

2004 2008 2012 Faculty member World (WHO) PAH Meeting

2010 Elected to Fellowship Pulmonary Vascular Reserach Institute

2014 President Pulmonary Vascular Research Institute

2019 Medical Director World Transplant Games

2019 Paul Corris Research Scholarship established at Newcastle University

I have given state of the art talks at all International Respiratory and Transplant meetings including ATS ERS BTS ESOT ISHLT Transplantation Society every year for 25 years and have been faculty member for short courses and master classes from BTS ERS and ISHLT every year

SELECTED ADDITIONAL CURRENT APPOINTMENTS

Clinical Advisor National Institute for Clinical Excellence

Medical Advisor Pulmonary Hypertension Association

National Clinical lead for collaborative studies in pulmonary hnypertension

Director Research Pulmonary hypertension Newcastle

1. Clinical trials including commercial with strong academic links with Bayer and Actelion. Preferred indusrty clinical triallist with Pfizer. Current clinical projects in hypoxic vasoconstriction in group 1 patients and peripheral muscle function in group 3 patients
2. Translational studies  using primary human endothelial cells
3. Genetic studies including whole genome sequencing in iPAH and cohort studies in BMPR2 mutation patients

RECENT RESEARCH GRANTS

2014-2015                   Bayer Scientific Research Grant     £99,000

                                    Riociguat in patients with respiratory disease and hypoxia

2013-2018                   BHF ref SP/12/12/29836                    £1,178,425

                                    National cohort study of heritable pulmonary hypertension

                                   Principal Investigator Prof Nick Morell Co Applicant Prof Paul Corris                                     

2013-2018                   MRC ref MR/K020919/1          £3,899,348

                                    Mechanisms underlying the development of pulmonary arterial hypertension

                                   Principal Investigator Prof Nick Morell Co applicant Prof Paul Corris

2012-2015                     McPhail Charitable Trust                  £147,000

                                    Clinical trials in pulmonary hypertension

2011-2015                     MRC ref G1100233                           £314,494  

Developmental Clinical Studies (DCS): Does GM-CSF restore effective neutrophil function in critically ill patients?

Chief investigator Prof John Simpson (Newcastle University). Co-applicant: Prof Paul Corris,

2012-2015                     Newcastle Healthcare Charity Award £111,768

A lipopolysaccharide (LPS) inhalation model to characterise divergent cellular innate immune responses early in the course of acute lung inflammation

Principal Investigator Prof John Simpson. Co-applicant Prof Paul Corris, ref BH110474

2009-2012                     Pfizer Academic Partnership              £120.000

                                    Novel end points in clnical trials of drugs in PAH

2006-2009                     Medical Research Council                    £516,000

                                    Azithromycin in OB    

2007 -2008                    AstraZeneca Academic Partnership      £285,000

                                    Biology of pulmonary vascular endothelial cells in emphysema

2008-2012                     Cystic Fibrosis Trust                            £500,000

                                    In vitro treatment of donor lungs to downregulate inflammation

                                    Co applicant

2008-2012                     Medical Research Council                    £127,000

                                    Endothelial cell biology and emphysema

I am involved in undergraduate teaching of Medical Students throughout the course.

I contribute greatly to postgraduate teaching of medicine within my specialist fields of Pulmonary Hypertension and Lung Transplantation on an International basis via specialist society state of art lecturess and masterclasses.

• Benza RL, Farber HW, Frost AE, Ghofrani H-A, Corris PA, Lambelet M, Nikkho S, Meier C, Hoeper MM. Application of the REVEAL risk score calculator 2.0 in the PATENT study. International Journal of Cardiology 2021, 332, 189-192.
• Kariotis S, Jammeh E, Swietlik EM, Pickworth JA, Rhodes CJ, Otero P, Wharton J, Iremonger J, Dunning MJ, Pandya D, Mascarenhas TS, Errington N, Thompson AAR, Romanoski CE, Rischard F, Garcia JGN, Yuan JX-J, An T-HS, Desai AA, Coghlan G, Lordan J, Corris PA, Howard LS, Condliffe R, Kiely DG, Church C, Pepke-Zaba J, Toshner M, Wort S, Graf S, Morrell NW, Wilkins MR, Lawrie A, Wang D, Bleda M, Hadinnapola C, Haimel M, Auckland K, Tilly T, Martin JM, Yates K, Treacy CM, Day M, Greenhalgh A, Shipley D, Peacock AJ, Irvine V, Kennedy F, Moledina S, MacDonald L, Tamvaki E, Barnes A, Cookson V, Chentouf L, Ali S, Othman S, Ranganathan L, Gibbs JSR, DaCosta R, Pinguel J, Dormand N, Parker A, Stokes D, Ghedia D, Tan Y, Ngcozana T, Wanjiku I, Polwarth G, Mackenzie Ross RV, Suntharalingam J, Grover M, Kirby A, Grove A, White K, Seatter A, Creaser-Myers A, Walker S, Roney S, Elliot CA, Charalampopoulos A, Sabroe I, Hameed A, Armstrong I, Hamilton N, Rothman AMK, Swift AJ, Wild JM, Soubrier F, Eyries M, Humbert M, Montani D, Girerd B, Scelsi L, Ghio S, Gall H, Ghofrani A, Bogaard HJ, Noordegraaf AV, Houweling AC, Veld AH, Schotte G, Trembath RC. Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nature Communications 2021, 12(1), 7104.
• Ghofrani H-A, Gomez Sanchez M-A, Humbert M, Pittrow D, Simonneau G, Gall H, Grunig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiery J-L, Wirtz H, Helmersen DS, Tsangaris I, Barbera JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Simkova I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM, Caneva J, Tuhay G, Diez M, Talavera ML, Acosta A, Vulcano N, Bosio M, Maldonado L, Deleo S, Melatini L, Keogh A, Kotlyar E, Feenstra J, Dwyer N, Adams H, Stevens W, Steele P, Proudman S, Minson R, Reeves G, Lavender M, Ng B, Mackenzie M, Barry L, Gruenberger M, Huber C, Lang I, Tilea I, Sadushi-Kolici R, Loffler-Ragg J, Feistmantl L-T, Evrard P, Louis R, Guiot J, Naldi M, De Pauw M, Mehta S, Camacho RC, Tovar PP, Londono A, Campo F, Garcia P, Lema C, Orozco-Levi M, Martinez W, Gomez JE, Nielsen-Kudsk JE, Mellemkjaer S, Anton L, Altraja A, Vihinen T, Vasankari T, Sitbon O, Cottin V, Tetu L, Noel-Savina E, Shearman N, Tayler S, Olzik I, Kulka C, Grimminger J, Simon M, Nolde A, Oqueka T, Harbaum L, Egenlauf B, Ewert R, Schulz C, Regotta S, Kramer T, Knoop-Busch S, Gerhardt F, Konstantinides S, Pitsiou G, Stanopoulos I, Sourla E, Mouratoglou S, Karvounis H, Pappas A, Georgopoulos D, Fanaridis M, Mitrouska I, Michalis L, Pappas K, Kotsia A, Gaine S, Vizza CD, Manzi G, Poscia R, Badagliacca R, Agostoni P, Bruno N, Farina S, D'Alto M, Argiento P, Correra A, Di Marco GM, Cresci C, Vannucchi V, Torricelli E, Garcea A, Pesci A, Sardella L, Paciocco G, Pane F, D'Armini AM, Pin M, Grazioli V, Massola G, Sciortino A, Prediletto R, Bauleo C, Airo E, Ndreu R, Pavlickova I, Lunardi C, Mule M, Farruggio S, Costa S, Galgano G, Petruzzi M, De Luca A, Lombardi F, Roncon L, Conte L, Picariello C, Wirtz G, Alexandre M, Vonk-Noordegraaf A, Boogaard H, Mager J, Reesink H, van den Toorn LM, Boomars K, Andreassen AK, Castro G, Tania G, Baptista R, Marinho A, Shiang T, Oliveira A, Coutinho D, Sousa J, Loureiro MJ, Repolho D, Martins Jesus SM, Capinha M, Agostinho J, Cardoso T, Rocha A, Espinha M, Ivanov KI, Alexeeva DE, Batalina MV, Hegya DV, Zvereva TN, Avdeev SN, Tsareva NA, Galyavich AS, Nikolaevich BA, Filippov EV, Yakovleva OE, Pavlova OB, Skripkina ES, Martynyuk TV, Bukatova IF, Tregubova AV, Platonov DY, Kolomeytseva TM, Al Dalaan A, Abdelsayed AA, Weheba I, Saleemi S, Sakkijha H, Bohacekova M, Valkovicova T, Farkasova I, Quezada CA, Piccari L, Blanco I, Sebastian L, Roman A, Lopez M, Otero R, Elias T, Jara L, Asencio I, Arjona JJ, Almagro RM, Cardenas SL, Garcia SA, Rodriguez PV, Lopez R, Garcia A, Aviles FF, De La Pava S, Yotti R, Penate GP, Marrero FL, Cifrian Martinez JM, Martinez-Menaca A, Alonso LP, Rozas SF, Fernandez DI, Cuesta VM, Soderberg S, Bartfay S-E, Rundqvist B, Alfetlawi M, Wodlin P, Schwarz EI, Speich R, Lador F, Rochat T, Gasche-Soccal P, Hsu C-H, Lin T-H, Su H-M, Lai W-T, Chu CY, Hsu P-C, Voon W-C, Yen H-W, Yih-Jer Wu J, Wu S-H, Huang W-P, Fong M-C, Huang C-L, Kuo P-H, Lin Y-H, Lin J-L, Hung C-S, Wu C-K, Sung S-H, Huang W-C, Cheng C-C, Kuo S-H, Wang W-H, Ho W-J, Hsu T-S, Mutlu B, Atas H, Ongen G, Un Z, Okumus G, Hanta I, Corris P, Peacock A, Church C, Toshner M, Newnham M. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry. Respiratory Medicine 2021, 178, 106220.
• Corris PA. Risk stratification in PAH. Global Cardiology Science and Practice 2020, 2020(1), 9.
• Corris PA. The importance of deep phenotyping PH registries with a focus on the PVRI-GoDeep registry. Global Cardiology Science and Practice 2020, 2020(1), 12.
• Graf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani H-A, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, Van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nature Communications 2018, 9(1), 1416.
• Tissot A, Thomas MF, Corris PA, Brodlie M. NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: A worldwide survey of clinical practice. BMC Pulmonary Medicine 2018, 18, 86.
• Birch J, Sunny SS, Hester KLM, Parry G, Kate Gould F, Dark JH, Clark SC, Meachery G, Lordan J, Fisher AJ, Corris PA, De Soyza A. Outcomes of lung transplantation in adults with bronchiectasis. BMC Pulmonary Medicine 2018, 18, 82.
• Sithamparanathan S, Rocha MC, Parikh JD, Rygiel KA, Falkous G, Grady JP, Hollingsworth KG, Trenell MI, Taylor RW, Turnbull DM, Gorman GS, Corris PA. Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study. Pulmonary Circulation 2018, 8(2), 1-5.
• Borthwick LA, Suwara MI, Carnell SC, Green NJ, Mahida R, Dixon D, Gillespie CS, Cartwright TN, Horabin J, Walker A, Olin E, Rangar M, Gardner A, Mann J, Corris PA, Mann DA, Fisher AJ. Pseudomonas aeruginosa induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction. American Journal of Transplantation 2016, 16(6), 1751-1765.
• Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, Treacy C, Ponnaberanam A, Condliffe R, Sheares K, Taboada D, Dunning J, Tsui S, Ng C, Gopalan D, Screaton N, Elliot C, Gibbs S, Howard L, Corris P, Lordan J, Johnson M, Peacock A, MacKenzie-Ross R, Schreiber B, Coghlan G, Dimopoulos K, Wort SJ, Gaine S, Moledina S, Jenkins DP, Pepke-Zaba J. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation 2016, 133(18), 1761-1771.
• Bayes HK, Ritchie ND, Ward C, Corris PA, Brodlie M, Evans TJ. IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection. Journal of Cystic Fibrosis 2016, 15(6), 759–768.
• Corris PA. Induction Therapy in Lung Transplantation? A Frustrating Message of Persisting Uncertainty. American Journal of Transplantation 2016, 16(8), 2250-2251.
• Sithamparanathan S, Thirugnanasothy L, Clark S, Dark JH, Fisher AJ, Gould KF, Hasan A, Lordan JL, Meachery G, Parry G, Corris PA. Observational study of lung transplant recipients surviving 20 years. Respiratory Medicine 2016, 117, 103-108.
• Fisher AJ, Yadegarfar ME, Collerton J, Small T, Kirkwood TBL, Davies K, Jagger C, Corris PA. Respiratory health and disease in a UK population-based cohort of 85 year olds: The Newcastle 85+ Study. Thorax 2016, 71(3), 255-266.
• Miller R, Hartog B, Frew J, Parry G, Fisher A, Corris P, Meachery G, Lordan J. Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience. In: 36th Annual Meeting of the International Society for Heart and Lung Transplantation. 2016, Washington, DC: Elsevier.
• Nathan SD, Corris PA. Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?. Thorax 2016, 71(2), 107-109.
• Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, Snell GI, Verleden GM, Zamora MR, Glanville AR. A consensus document for the selection of lung transplant candidates: 2014-An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. Journal of Heart and Lung Transplantation 2015, 34(1), 1-15.
• Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C. A randomised controlled trial of azithromycin therapy in Bronchiolitis Obliterans Syndrome (BOS) post lung transplantation . Thorax 2015, 70(5), 442-450.
• Brodlie M, Aseeri A, Lordan JL, Robertson AGN, McKean MC, Corris PA, Griffin SM, Manning NJ, Pearson JP, Ward C. Bile acid aspiration in people with cystic fibrosis before and after lung transplantation. European Respiratory Journal 2015, 46(6), 1820-1823.
• Klinger J, Hoeper MM, Benza R, Simonneau G, Langleben D, Naeije R, Corris PA. Biomarkers in the Respite Trial Investigating Riociguat in PAH Patients with Insufficient Response to PDE-5I. In: International Academy of Cardiology Annual Scientific Sessions 2015. 20th World Congress on Heart Disease. 2015, Vancouver, B.C., Canada: Karger.
• Glanville AR, Aboyoun C, Klepetko W, Reichenspurner H, Treede H, Verschuuren EA, Boehler A, Benden C, Hopkins P, Corris PA, European & Australian Invest Lung. Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation. Journal of Heart and Lung Transplantation 2015, 34(1), 16-25.
• Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. Journal of Heart and Lung Transplantation 2014, 33(2), 127-133.
• Sithamparanathan S, Thirugnanasothy L, Fisher AJ, Lordan J, Meachery G, Dark JH, Hasan A, Clark SC, Gould K, MacGowan GA, Parry G, Corris PA. A Retrospective Observational Study of 20 Year Lung Transplant Survivors - A Single Centre Experience. In: British Thoracic Society Winter Meeting. 2014, London, UK: BMJ Publishing Group.
• Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR, ISHLT ATS ERS BOS Task Force Comm. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. European Respiratory Journal 2014, 44(6), 1479-1503.
• Corte TJ, Keir GJ, Dimopoulos K, Howard L, Corris PA, Parfitt L, Foley C, Yanez-Lopez M, Babalis D, Marino P, Maher TM, Renzoni EA, Spencer L, Elliot CA, Birring SS, O'Reilly K, Gatzoulis MA, Wells AU, Wort SJ, BPHIT Study Group. Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine 2014, 190(2), 208-217.
• Suwara MI, Green NJ, Borthwick LA, Mann J, Mayer-Barber KD, Barron L, Corris PA, Farrow SN, Wynn TA, Fisher AJ, Mann DA. IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunology 2014, 7(3), 684-693.
• McDonnell MJ, Anwar GA, Rutherford RM, De Soyza A, Worthy S, Corris PA, Lordan JL, Bourke S, Afolabi G, Ward C, Middleton P, Middleton D. Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis. Respiratory Medicine 2014, 108(8), 1127-1133.
• Suwara MI, Vanaudenaerde BM, Verleden SE, Vos R, Green NJ, Ward C, Borthwick LA, Vandermeulen E, Lordan J, Van Raemdonck DE, Corris PA, Verleden GM, Fisher AJ. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation. Transplant International 2014, 27(8), 857-867.
• Pison C, Magnan A, Botturi K, Seve M, Brouard S, Marsland BJ, Ernst F, Paprotka T, Deplanche K, Fritz A, Siroux V, Boissel JP, Corris PA, Auffray C, Nicod LP, on behalf of the SysCLAD Consortium. Prediction of chronic lung allograft dysfunction: a systems medicine challenge. European Respiratory Journal 2014, 43(3), 689-693.
• Shah KB, Kwakkel-van Erp JM, Migliore C, Orr Y, Corris PA, Glanville AR, Slaughter MS, West LJ, Mehra MR. Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: Highlights from the Journal of Heart and Lung Transplantation. Journal of Heart and Lung Transplantation 2014, 33(3), 223-228.
• Andreasson A, Karamanou DM, Perry JD, Perry A, Özalp F, Butt T, Morley KE, Walden HR, Clark SC, Prabhu M, Corris PA, Gould K, Fisher AJ, Dark JH. The effect of ex vivo lung perfusion on microbial load in human donor lungs. Journal of Heart and Lung Transplantation 2014, 33(9), 910-916.
• Corris PA, Sithamparanathan S, Thirugnanasothy L. The good the bad and the ugly. Thorax 2014, 69(9), 870-871.
• Verleden SE, Ruttens D, Bijnens E, Winckelmans E, Meloni F, Morosini M, Gottlieb J, Warnecke G, Verschuuren E, Van der Bij W, Weinreich G, Kamler M, Sommerwerck U, Hoffmann B, Roman A, Olles SG, Benden C, Rechsteiner T, Luijck B, Oudijk E, Van Kessel D, Kwakkel-Van Erp J, Iversen M, Schultz H, Jaksch P, Klepetko W, Lordan J, Corris P, Fisher A, Holm A, Vandermeulen E, Vos R, Kneidinger N, Neurohr C, Beelen R, Vienneau D, Hoek G, De Hoogh K, Nemery B, Verleden GM, Nawrot TS, Vanaudenaerde B. The Impact of Air Pollution on Outcome After Lung Transplantation in Europe. In: International Society for Heart and Lung Transplantation 34th Annual Meeting and Scientific Sessions. 2014, San Diego, California, USA: Elsevier.
• Woolcock SC, De Soyza J, Crockett R, Day M, Fisher AJ, Lordan J, MacGowan G, Corris PA. The Role of Specialist Palliative Care Services in the Management of Patients with Pulmonary Arterial Hypertension; A Review of Current Practice. In: British Thoracic Society. 2014, London, UK: BMJ Publishing Group.
• Gries CJ, White DB, Truog RD, DuBois J, Cosio CC, Dhanani S, Chan KM, Corris PA, Dark J, Fulda G, Glazier AK, Higgins R, Love R, Mason DP, Nakagawa TA, Shapiro R, Shemie S, Tracy MF, Travaline JM, Valapour M, West L, Zaas D, Halpern SD. An Official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: Ethical and Policy Considerations in Organ Donation after Circulatory Determination of Death. American Journal of Respiratory and Critical Care Medicine 2013, 188(1), 103-109.
• Parikh S, Brownlee IA, Robertson AG, Manning NT, Johnson GE, Brodlie M, Corris PA, Ward C, Pearson JP. Are the enzymatic methods currently being used to measure bronchoalveolar lavage bile salt levels fit for purpose?. Journal of Heart and Lung Transplantation 2013, 32(4), 418-423.
• Ruchaud-Sparagano MH, Gertig H, Hester KL, Macfarlane JG, Corris P, Simpson AJ, De Soyza A. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. Respirology 2013, 18(8), 1230-1235.
• Yorke J, Corris P, Gaine S, Gibbs SS, Kiely DG, Harries C, Pollock V, Armstrong I. emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. European Respiratory Journal 2013, 43(4), 1106-1113.
• Thakrar MV, Hall A, Crackett R, Day M, Mac Gowan G, Lordan JL, Fisher AJ, Treacey C, Pepke-Zaba J, Corris PA. Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension. In: ISHLT 33rd Annual Meeting & Scientific Sessions. 2013, Montreal, Canada: Elsevier.
• Krishnan A, Perry A, Robertson A, Brodlie M, Perry J, Corris P, Griffin M, Gould K, Forrest I, Pearson J, Ward C. Identical Biofilm Forming Strains of Pseudomonas aeruginosa Occur in Lung Allograft BAL and Gastric Juice from CF Patients with Gastro Oesophageal Reflux. In: ISHLT 33rd Annual Meeting & Scientific Sessions. 2013, Montreal, Canada: Elsevier.
• Ranasinghe AM, Clark S, Corris PA, Fisher AJ, Gould K, Hamilton L, Lordan JL, Meachery G, Morley K, Parry G, Perry A, Pillay T, Schueler S, Tocewicz K, Dark TH. Improving Outcomes in Lung Transplantation for Cystic Fibrosis - A Unified Approach. In: ISHLT 33rd Annual Meeting & Scientific Sessions. 2013, Montreal, Canada: Elsevier.
• Mackay LS, Dodd S, Dougall IG, Tomlinson W, Lordan J, Fisher AJ, Corris PA. Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema. Respiratory Research 2013, 14, 23.
• Corris PA. Lung Transplantation for Cystic Fibrosis and Bronchiectasis. Seminars in Respiratory and Critical Care Medicine 2013, 34(3), 297-304.
• Anwar GA, McDonnell MJ, Worthy SA, Bourke SC, Afolabi G, Lordan J, Corris PA, De Soyza A, Middleton P, Ward C, Rutherford RM. Phenotyping adults with non-cystic fibrosis bronchiectasis: A prospective observational cohort study. Respiratory Medicine 2013, 107(7), 1001-1007.
• Thakrar MV, Morley K, Lordan JL, Meachery GJ, Fisher AJ, Parry G, Corris PA. Pregnancy after Lung Transplantation: A Single Center Experience. In: ISHLT 33rd Annual Meeting & Scientific Sessions. 2013, Montreal, Canada: Elsevier.
• Corris PA. Remembering Robyn Barst. Journal of Heart and Lung Transplantation 2013, 32(7), 750-750.
• Corris PA. Remembering Robyn Barst. Journal of Heart and Lung Transplantation 2013, 32(7), 750-750.
• Pavord ID, Thomson NC, Niven RM, Corris PA, Chung KF, Cox G, Armstrong B, Shargill NS, Laviolette M. Safety of bronchial thermoplasty in patients with severe refractory asthma. Annals of Allergy, Asthma and Immunology 2013, 111(5), 402-407.
• Borthwick LA, Corris PA, Mahida R, Walker A, Gardner A, Suwara M, Johnson GE, Moisey EJ, Brodlie M, Ward C, Perry JD, de Soyza A, Mann DA, Fisher AJ. TNFα From Classically Activated Macrophages Accentuates Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis. American Journal of Transplantation 2013, 13(3), 621-633.
• Crackett RM, Hall A, Day MB, Desoyza JR, Small T, Fisher AJ, Lordan JL, Mac Gowan G, Corris PA. Treatment Outcomes in Pulmonary Arterial Hypertension (PHA) Associated with Systemic Sclerosis (Sscl.) in Matched Groups Using Either Bosentan or Sildenafil Monotherapy. In: ISHLT 33rd Annual Meeting & Scientific Sessions. 2013, Montreal, Canada: Elsevier.
• Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A. Updated Treatment Algorithm of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology 2013, 62(25), D60-D72.
• Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. American Journal of Respiratory and Critical Care Medicine 2012, 186(8), 790-796.
• Burdett CL, Butt T, Archer L, Morley K, Searl CP, Corris PA, Parry G, Gould FK, Dark JH. Evolving Experience with Donor Lung Bronchoalveolar Lavage. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2011, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Laviolette M, Shargill NS, Cox G, AIR Trial Study Group. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulmonary Medicine 2011, 11, 8.
• Small TM, Ward C, Lordan JL, Fisher AJ, Corris PA, Gibson GJ. Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome. In: IRISH JOURNAL OF MEDICAL SCIENCE. 2010, 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND: SPRINGER LONDON LTD.
• Wearmoutb DA, Rennison C, Fisher A, Lordan J, Corris PA, Gould FK. Effectiveness of Targeted Pro-Active Management of Aspergillus fumigatus Infections before and after Lung Transplantation. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2009, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Burdett CL, Critchley R, Black F, Barnard S, Clark SC, Corris PA, Gould KF, Butt T, Dark JH. Invasive Biopsy Is Effective and Useful after Lung Transplant. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2009, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JSR, Pepke-Zaba J, Coghlan JG. Survival in Systemic Sclerosis-related Pulmonary Arterial Hypertension in the Modern Treatment Era. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2009, 180(12), 1280-1281.
• Small TM, Ward C, Yates B, Murphy DM, Forrest IA, Lordan JL, Fisher AF, Dark JH, Corris PA. Azithromycin reverses airflow obstruction in established bronchicilitis obliterans syndrome - A three year follow up. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Maxwell S, McCall A, Corris PA, Gibson GJ, Lordan JL, Ward A, Fisher AJ, Higgins BG, De Soyza A. CARELESS NOTE-TAKING COSTS MONEY: LESSONS FROM A CODING AUDIT OF RESPIRATORY HOSPITAL EPISODES. In: THORAX. 2008, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND: B M J PUBLISHING GROUP.
• Botha P, Wrightson N, Butt T, Corris PA, Dark JH, Fisher AJ, Schueler SVB. Safe extension of ischaemic time in lung transplantation - Where is the limit?. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Condliffe R, Kiely DG, Peacock A, Corris PA, Gibbs JSR, Pepke-Zaba J, Coghlan JG. Initial results of the united kingdom audit of pulmonary arterial hypertension associated with connective tissue disease (CTD-PAH). In: EUROPEAN HEART JOURNAL. 2007, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND: OXFORD UNIV PRESS.
• Cooper D, Kerr J, Parry G, Dark JH, Lordan J, Corris PA, Fisher AJ. Lung transplantation for idiopathic pulmonary fibrosis: Recipient characteristics and survival outcomes in a single centre 1987-2007. In: THORAX. 2007, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND: B M J PUBLISHING GROUP.
• Mackay LS, Anderson RL, Lordan J, Corris PA, Fisher AJ. Factors influencing survival to lung transplantation in patients with idiopathic pulmonary fibrosis placed on the waiting list 1999-2004. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2006, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Wearmouth DA, Archer L, Corris PA, Dark JH, Gould FK. Successful outcome following lung transplantion for recipients colonised with filamentous fungi at time of transplant. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2005, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Archer L, Morris K, Perry JD, Dark JH, Corris PA, Gould FK. Use of the multi combination bactericidal test to detect optimal antimicrobial combinations for the treatment of Pseudomonas aeruginosa and Burkholderia cepacia in patients undergoing lung transplantation. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2005, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• BROWN AL, CORRIS PA, ASHCROFT T, WILKINSON R. AZATHIOPRINE-RELATED INTERSTITIAL PNEUMONITIS IN A RENAL-TRANSPLANT RECIPIENT. NEPHROLOGY DIALYSIS TRANSPLANTATION 1992, 7(4), 362-364.